Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|April 1, 2004
Vapocoolant spray pre-treatment eases pain of palmar injections
Washington D.C. -- Cryoanesthesia using the refrigerant spray dichlorotetrafluoroethane (Freon 114; Frigiderm) safely and effectively reduces the pain of botulinum toxin type A (Botox) injections for palmar hyperhidrosis but does not interfere with the efficacy of that treatment for decreasing sweating, said Leslie S. Baumann, M.D., at the annual meeting of the American Academy of Dermatology here.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
4
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
5